| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.18 | 0.0004 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.15 | 0.004 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.1 | 0.04 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.09 | 0.07 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.085 | 0.07 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.085 | 0.07 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.065 | 0.2 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.057 | 0.2 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.056 | 0.2 |